Neuralink develops implantable brain-computer interfaces (BCIs) that convert neural signals into commands for digital devices. The company's primary product, the N1 implant, is a fully implanted, cosmetically invisible system designed to enable direct neural control of computers and mobile devices. The technical stack spans neuroscience, microscale electronics, and biomedical engineering, requiring integration of high-channel-count electrode arrays, custom ASICs for signal acquisition, and biocompatible packaging capable of long-term implantation.
The N1 implant uses a robot-assisted surgical system for precise electrode insertion into cortical tissue. The system must handle constraints common to implantable neurotechnology: minimizing tissue damage during placement, maintaining stable chronic recordings, managing power and thermal dissipation within the implant envelope, and wirelessly transmitting high-bandwidth neural data through skin without percutaneous connectors. Signal processing pipelines must extract intent from noisy, non-stationary neural recordings in real time.
Neuralink has received FDA approval to conduct human clinical trials with the N1 implant. The company's work operates at the intersection of medical device regulation and cutting-edge neuroengineering, with engineering challenges that span from MEMS-scale fabrication and hermetic sealing to embedded firmware and machine-learning–based neural decoders running on constrained compute platforms.